New Upside Potential Drives JPMorgan's Eli Lilly Upgrade

By: via Benzinga
JPMorgan has upgraded Eli Lilly and Co (NYSE: LLY) to Overweight from Neutral based on the potential for new product driven upside to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.